commercialisation

R&D

Driving data & analytics transformation in life sciences

The field of life sciences is witnessing a remarkable era of innovation, characterised by breakthroughs across scientific domains that are revolutionising drug discovery and development.

Sales & Marketing

Life sciences must reinvent the commercial model to keep pac...

The past five years have witnessed extraordinary progress in life sciences, marked by unprecedented innovation and achievements.

R&D

How to transition from lab to commercial-scale ATMP Manufact...

This is the first article of our series, “The ATMP Manufacturer’s Guide to Commercialisation and cGMP Compliance”.

R&D

Creating healthier futures - Reuters Pharma Barcelona 2023

In this latest mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Tommy Bramley, SVP of global consulting at Amerisource Bergen, whilst attending Reuters Pharma Barcelona.

Market Access

Navigating Routes to Commercial Excellence in Cell and Gene ...

'Navigating Routes to Commercial Success in Cell and Gene Therapy', authored by Franjo Hanzl, VP, Business Development, Commercial at EVERSANA, Dr.

News

AstraZeneca, C4XD sign exclusive $402 million global licence

C4X Discovery Holdings has signed an exclusive global licence worth up to $402 million with AstraZeneca (AZ) for the development and commercialisation of the NRF2 Activator programme.